We are live on ! Find out more
OFIX icon

Orthofix Medical

158 hedge funds and large institutions have $400M invested in Orthofix Medical in 2025 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 71 increasing their positions, 34 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

109% more repeat investments, than reductions

Existing positions increased: 71 | Existing positions reduced: 34

6.6% more ownership

Funds ownership: 85.07%91.68% (+6.6%)

0% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 27

1% less funds holding

Funds holding: 160158 (-2)

25% less funds holding in top 10

Funds holding in top 10: 43 (-1)

26% less capital invested

Capital invested by funds: $541M → $400M (-$141M)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $24K

Holders
158
Holders Change
-2
Holders Change %
-1.25%
% of All Funds
2.08%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.04%
New
27
Increased
71
Reduced
34
Closed
27
Calls
Puts
$24K
Net Calls
-$24K
Net Calls Change
+$4K
Name Holding Trade Value Shares
Change
Change in
Stake
Tudor Investment Corp
51
Tudor Investment Corp
Connecticut
$656K -$1.51M -121,720 -67%
MAM
52
Monaco Asset Management
Monaco
$629K +$698K +56,369 New
Susquehanna International Group
53
Susquehanna International Group
Pennsylvania
$612K +$107K +8,627 +19%
GSIS
54
Global Strategic Investment Solutions
Arizona
$558K
AllianceBernstein
55
AllianceBernstein
Tennessee
$551K -$601K -48,470 -50%
DTL
56
Dynamic Technology Lab
Singapore
$535K +$158K +12,732 +36%
T. Rowe Price Associates
57
T. Rowe Price Associates
Maryland
$510K +$47.4K +3,826 +9%
CCP
58
Clough Capital Partners
Massachusetts
$487K -$1.66M -133,771 -75%
AG
59
Algert Global
California
$474K -$1.71M -137,774 -76%
HIM
60
Hillsdale Investment Management
Ontario, Canada
$471K +$149K +12,000 +40%
YIH
61
Y-Intercept (HK)
Hong Kong
$467K +$518K +41,844 New
Boston Partners
62
Boston Partners
Massachusetts
$444K +$743 +60 +0.2%
KMC
63
Kirr Marbach & Co
Indiana
$440K
Ameriprise
64
Ameriprise
Minnesota
$429K +$477K +38,462 New
EMFAT
65
Emerald Mutual Fund Advisers Trust
Pennsylvania
$420K -$5.91M -476,899 -93%
FMI
66
F/M Investments
District of Columbia
$420K +$6.23K +503 +1%
AI
67
Atom Investors
Texas
$412K +$458K +36,975 New
TC
68
Tejara Capital
United Kingdom
$405K +$66.4K +5,362 +17%
Legal & General Group
69
Legal & General Group
United Kingdom
$403K +$6.17K +498 +1%
II
70
Inspire Investing
Idaho
$397K +$180K +14,506 +69%
PAM
71
Panagora Asset Management
Massachusetts
$394K
TCWA
72
Turtle Creek Wealth Advisors
Texas
$392K
Prudential Financial
73
Prudential Financial
New Jersey
$386K +$429K +34,662 New
PCM
74
Polymer Capital Management
New York
$380K +$228K +18,397 +117%
California State Teachers Retirement System (CalSTRS)
75
California State Teachers Retirement System (CalSTRS)
California
$358K

OFIX Hedge Fund Activity: Q2 2025 in Review

158 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Orthofix Medical (OFIX) for Q2 2025, worth a combined $400M — down 26% from $541M a quarter earlier.

Fund positioning in OFIX was balanced in Q2 2025: 27 funds opened new positions, 27 closed out, 71 added to existing stakes and 34 trimmed.

The largest buyer was Paradigm Capital Management Inc, adding an estimated $10.6M. The largest seller was Boone Capital Management, exiting entirely with an estimated $15.5M sold.

  • 158 institutional investors held Orthofix Medical (OFIX) as of Q2 2025, down from 160 in Q1 2025.
  • Funds reported $400M of Orthofix Medical stock for Q2 2025, down 26% quarter-over-quarter.
  • 27 funds opened new Orthofix Medical positions in Q2 2025 and 27 closed out, a net change of 0 holders.
  • The largest Orthofix Medical buyer in Q2 2025 was Paradigm Capital Management Inc, an estimated $10.6M added.
  • The largest Orthofix Medical seller in Q2 2025 was Boone Capital Management, an estimated $15.5M sold.

Based on aggregated 13F filings for Q2 2025.